Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Salgado

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Arquivos Brasileiros De Cardiologia|January 20, 2010
Music therapy effects on the quality of life and the blood pressure of hypertensive patientsClaudia Regina de Oliveira Zanini, Paulo César Brandão Veiga Jardim, Claudia Maria Salgado, et al.
Vaccines|December 11, 2019
Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMixWesley de Jong, Lorna Leal, Jozefien Buyze, et al.
The Journal of Clinical Investigation|November 29, 2024
Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoirIrene González-Navarro, Víctor Urrea, Cristina Gálvez, et al.
Clinical Epigenetics|January 4, 2024
Malignant peripheral nerve sheath tumor (MPNST) and MPNST-like entities are defined by a specific DNA methylation profile in pediatric and juvenile populationSara Patrizi, Evelina Miele, Lorenza Falcone, et al.
AIDS (London, England)|October 6, 2018
Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infectionLorna Leal, Alberto C Guardo, Sara Morón-López, et al.
The Lancet. HIV|March 15, 2020
Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case reportRavindra Kumar Gupta, Dimitra Peppa, Alison L Hill, et al.
Nature Medicine|September 2, 2024
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cellsAsier Sáez-Cirión, Anne-Claire Mamez, Véronique Avettand-Fenoel, et al.
Science Translational Medicine|May 8, 2020
Vulnerability to reservoir reseeding due to high immune activation after allogeneic hematopoietic stem cell transplantation in individuals with HIV-1Johanna M Eberhard, Mathieu Angin, Caroline Passaes, et al.
Nature|March 6, 2019
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantationRavindra K Gupta, Sultan Abdul-Jawad, Laura E McCoy, et al.
The Journal of Infectious Diseases|April 18, 2015
A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral LoadsKelly A Metcalf Pate, Christopher W Pohlmeyer, Victoria E Walker-Sperling, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Arquivos Brasileiros De Cardiologia|January 20, 2010
Music therapy effects on the quality of life and the blood pressure of hypertensive patientsClaudia Regina de Oliveira Zanini, Paulo César Brandão Veiga Jardim, Claudia Maria Salgado, et al.
Vaccines|December 11, 2019
Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMixWesley de Jong, Lorna Leal, Jozefien Buyze, et al.
The Journal of Clinical Investigation|November 29, 2024
Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoirIrene González-Navarro, Víctor Urrea, Cristina Gálvez, et al.
Clinical Epigenetics|January 4, 2024
Malignant peripheral nerve sheath tumor (MPNST) and MPNST-like entities are defined by a specific DNA methylation profile in pediatric and juvenile populationSara Patrizi, Evelina Miele, Lorenza Falcone, et al.
AIDS (London, England)|October 6, 2018
Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infectionLorna Leal, Alberto C Guardo, Sara Morón-López, et al.
The Lancet. HIV|March 15, 2020
Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case reportRavindra Kumar Gupta, Dimitra Peppa, Alison L Hill, et al.
Nature Medicine|September 2, 2024
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cellsAsier Sáez-Cirión, Anne-Claire Mamez, Véronique Avettand-Fenoel, et al.
Science Translational Medicine|May 8, 2020
Vulnerability to reservoir reseeding due to high immune activation after allogeneic hematopoietic stem cell transplantation in individuals with HIV-1Johanna M Eberhard, Mathieu Angin, Caroline Passaes, et al.
Nature|March 6, 2019
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantationRavindra K Gupta, Sultan Abdul-Jawad, Laura E McCoy, et al.
The Journal of Infectious Diseases|April 18, 2015
A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral LoadsKelly A Metcalf Pate, Christopher W Pohlmeyer, Victoria E Walker-Sperling, et al.
Pageof 8